Skip to main content
. Author manuscript; available in PMC: 2014 Oct 20.
Published in final edited form as: Hepatology. 2010 Apr;51(4):1168–1175. doi: 10.1002/hep.23477

Table 7. KIR2DL3 and Group 1 HLA-C Associations in the Spontaneously Resolving Cohort.

Resolved n (%) Persistent n (%) P Value (Pc) OR (95% CI)
Number of patients 122 219
KIR2DL3 and HLA-C alleles
 2DL3+Cw*01 7 (5.7) 10 (4.6) 0.42
 2DL3+Cw*03 38 (31.2) 42 (19.2) 0.01 (0.08) 1.9 (1.1-3.2)
 2DL3+Cw*07 70 (57.4) 115 (52.5) 0.38
 2DL3+Cw*08 12 (8.2) 11 (5.0) 0.09 (>0.1) 2.06 (0.82-5.21)
 2DL3+Cw*12 11 (9.0) 13 (5.9) 0.26
 2DL3+Cw*14 1 (0.8) 3 (1.4) 0.65
 2DL3+Cw*16 10 (8.2) 18 (8.2) 0.99
KIR2DL3 number and HLA-Cw*03
 2DL2/2DL3+Cw*03 14 (11.4) 20 (9.1) 0.49
 2DL3/2DL3+Cw*03 23 (18.9) 20 (9.1) 0.01 (0.02) 2.3 (1.2-4.4)